Veru (VERU) Projected to Post Earnings on Thursday

Veru (NASDAQ:VERU - Get Free Report) is expected to announce its earnings results before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $3.02 million for the quarter.

Veru (NASDAQ:VERU - Get Free Report) last announced its quarterly earnings data on Monday, December 16th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.01. Veru had a negative net margin of 223.85% and a negative return on equity of 92.88%. On average, analysts expect Veru to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Veru Price Performance

Shares of NASDAQ VERU traded up $0.01 during mid-day trading on Wednesday, reaching $0.57. 1,911,266 shares of the company's stock traded hands, compared to its average volume of 5,715,584. The stock has a market cap of $84.02 million, a P/E ratio of -2.04 and a beta of -0.54. The business has a 50-day simple moving average of $0.74 and a 200 day simple moving average of $0.78. Veru has a 1-year low of $0.36 and a 1-year high of $1.92.

Analysts Set New Price Targets

Several brokerages have commented on VERU. Oppenheimer restated an "outperform" rating and issued a $5.00 target price on shares of Veru in a research note on Tuesday, November 5th. HC Wainwright reaffirmed a "buy" rating and issued a $3.00 target price on shares of Veru in a research note on Thursday, January 2nd.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.